Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo | IMSEAR | ID: sea-183918

RESUMO

Background: Background: There are few studies of depression in Indian population which have looked at depression comprehensively covering various facets in a sample population. The objective of the current study was to recognize the clinical features and comorbidities of depression among inpatients in a tertiary care centre. Method: This was an observational study in which 50 patients admitted with ICD-10 diagnosis of depression were assessed for clinical symptomatology and comorbidity. Results: The mean number of somatic symptoms was 11.44 (SD 6.66), and the mean number of stressful life events over lifetime and in past 1 year were 8.02 (SD 3.8) and 1.44 (SD 1.18), respectively. One fifth of the sample (20%) had personality disorder; among them, mixed personality disorder (12%) was the most common diagnosis. Most of the patients had suicidal ideation (62%) and 26% had attempted suicide during their lifetime. Majority (60%) had atleast one psychiatric comorbidity; the most common being anxiety disorder (46%). Physical comorbidity was present in 54% of the patients; the common diagnoses were hypertension (18%), diabetes mellitus (14%) and ischaemic heart disease (12%). Conclusion: The current study found somatic symptoms and suicide ideation to be frequent in the sample. Also, comorbid conditions including personality disorders are frequent in patients with depression.

2.
J Ayurveda Integr Med ; 2012 Oct-Dec; 3(4): 223-225
Artigo em Inglês | IMSEAR | ID: sea-173222

RESUMO

Brahmi (Bacopa monnieri), an Ayurvedic herb has primarily been used to enhance cognitive ability, memory and learning skills. We present a case study of schizophrenia in which add-on Brahmi extracts 500 mg/day for a period of one month resulted in reduction in psychopathology without any treatment-emergent adverse effect. Although preliminary, our case study suggests therapeutic efficacy of add-on Brahmi in schizophrenia, thus opening up a new dimension of its role in alternative medicines.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA